Thermo Fisher Q2 revenue $10.97B (+18% YoY); GAAP EPS $4.22, adjusted EPS $5.51

THERMO FISHER SCIENTIFIC INC.

2022-Q2 EPS reported $9.83 revenue$22,788,000,000

Revenue $10.97B (+18% YoY); core organic growth 13%; COVID testing revenue $0.63B.
GAAP diluted EPS $4.22 vs $4.61 YoY; adjusted EPS $5.51 vs $5.60 YoY.
Adjusted operating margin 23.7% vs 29.0% YoY; GAAP operating income $2.00B.
Launched new products including Gibco CTS TrueCut Cas9 and Phadia 2500+ series.
Company to provide updated 2022 financial guidance during earnings call.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.